Literature DB >> 27511443

NSAID-induced symptomatic hypophosphataemia.

Morten Sommerfeldt Skeid1, Ulrik Pedersen-Bjergaard2, Peter Lommer Kristensen2, Lisbet Brandi2.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27511443      PMCID： PMC5061786          DOI： 10.1111/bcp.13061

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  12 in total

1.  Investigating hypophosphataemia.

Authors:  Paul Glendenning; Damon A Bell; Roderick J Clifton-Bligh
Journal:  BMJ       Date:  2014-05-28

2.  The Concise Guide to PHARMACOLOGY 2015/16: Transporters.

Authors:  Stephen Ph Alexander; Eamonn Kelly; Neil Marrion; John A Peters; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2015-12       Impact factor: 8.739

3.  Severe hypophosphatemia in hospitalized patients.

Authors:  J Halevy; S Bulvik
Journal:  Arch Intern Med       Date:  1988-01

Review 4.  Refeeding syndrome and hypophosphatemia.

Authors:  Mark A Marinella
Journal:  J Intensive Care Med       Date:  2005 May-Jun       Impact factor: 3.510

5.  Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism.

Authors:  Takehisa Kawata; Yasuo Imanishi; Keisuke Kobayashi; Takami Miki; Andrew Arnold; Masaaki Inaba; Yoshiki Nishizawa
Journal:  J Am Soc Nephrol       Date:  2007-09-12       Impact factor: 10.121

Review 6.  Salicylate-induced proximal tubular dysfunction.

Authors:  Vasilis Tsimihodimos; Nikolaos Psychogios; Varvara Kakaidi; Eleni Bairaktari; Moses Elisaf
Journal:  Am J Kidney Dis       Date:  2007-09       Impact factor: 8.860

Review 7.  Genetic diseases of renal phosphate handling.

Authors:  Carsten A Wagner; Isabel Rubio-Aliaga; Jürg Biber; Nati Hernando
Journal:  Nephrol Dial Transplant       Date:  2014-09       Impact factor: 5.992

8.  Correction of proximal tubule phosphate transport defect in Hyp mice in vivo and in vitro with indomethacin.

Authors:  Michel Baum; Samer Loleh; Neel Saini; Mouin Seikaly; Vangipuram Dwarakanath; Raymond Quigley
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-02       Impact factor: 11.205

9.  Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy.

Authors:  M Broman; O Carlsson; H Friberg; A Wieslander; G Godaly
Journal:  Acta Anaesthesiol Scand       Date:  2010-10-29       Impact factor: 2.105

10.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands.

Authors:  Christopher Southan; Joanna L Sharman; Helen E Benson; Elena Faccenda; Adam J Pawson; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Michael Spedding; William A Catterall; Doriano Fabbro; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2015-10-12       Impact factor: 16.971
View more
  1 in total

Review 1.  The Causes of Hypo- and Hyperphosphatemia in Humans.

Authors:  Eugénie Koumakis; Catherine Cormier; Christian Roux; Karine Briot
Journal:  Calcif Tissue Int       Date:  2020-04-13       Impact factor: 4.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.